Glaukos Corp.
$172.15
Mkt Cap 10.15B
Maker of ophthalmic devices, including an implant that delivers glaucoma medication inside the eye and a treatment for keratoconus that avoids traditional corneal cross-linking surgery.
glaukos.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
REVENUE TTM
$612.8M
FCF TTM
-$12.2M
Running full 6-factor analysis…